Huaren Pharmaceutical Co., Ltd. (300110.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 3.72B |
| Enterprise Value | 4.19B |
| P/E Ratio | -6.83 |
| PEG Ratio | -0.11 |
| Price/Sales Ratio | 2.49 |
| Price/Book Ratio | 3.74 |
| Enterprise/Revenue | 3.07 |
| Enterprise/EBITDA | -11.67 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.36 |
| Operating Margin | -0.35 |
| Return On Assets | -0.17 |
| Return On Equity | -0.48 |
| Revenue | 1.32B |
| Revenue/Share | 1.1 |
| Gross Profit | 489.54M |
| EBITDA | -308.5M |
| Net Income | -462.9M |
| Diluted EPS | -0.39 |
| Total Cash | 212.74M |
| Total Cash/Share | 0.18 |
| Total Debt | 976.37M |
| Total Debt/Equity | 1.13 |
| Current Ratio | 0.8 |
| Book Value Per Share | 0.8 |
| 52-Week Change | -19.41 |
| 52-Week High | 3.66 |
| 52-Week Low | 2.41 |
| Moving Average 50 Days | 2.78 |
| Moving Average 200 Days | 3.03 |
| Average Volume | 26.42M |
| Shares Outstanding | 1.18B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.05 |
| Last Split Factor | 287:250 |
| Last Split Date | February 09, 2018 |